Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Net Sales	$ 1,226.1	$ 1,988.6	$ 3,009.9	$ 3,964.1
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 424.5	$ 581.3	$ 911.6	$ 1,134.7
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 147.7	$ 146.9	$ 295.3	$ 290.3
Research and development	87.7	112.1	186.1	213.8
Selling, general and administrative	665.0	838.8	1,493.9	1,635.2
Goodwill and intangible asset impairment	33.0	70.1	645.0	70.1
Restructuring and other cost reduction initiatives	28.0	6.9	73.0	11.6
Quality remediation	9.7	22.7	26.1	42.4
Acquisition, integration and related	2.2	5.1	6.6	11.1
Operating expenses	1,397.8	1,783.9	3,637.6	3,409.2
Operating (Loss) Profit	(171.7)	204.7	(627.7)	554.9
Other income (expense), net	3.8	(4.7)	6.8	(5.2)
Interest expense, net	(54.0)	(59.7)	(104.9)	(117.7)
(Loss) earnings before income taxes	(221.9)	140.3	(725.8)	432.0
(Benefit) provision for income taxes	(13.7)	8.4	(8.5)	53.9
Net (Loss) Earnings	(208.2)	131.9	(717.3)	378.1
Less: Net loss attributable to noncontrolling interest	(1.6)	(1.8)	(2.2)	(1.7)
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc.	$ (206.6)	$ 133.7	$ (715.1)	$ 379.8
(Loss) Earnings Per Common Share
Basic	$ (1.00)	$ 0.65	$ (3.46)	$ 1.86
Diluted	$ (1.00)	$ 0.65	$ (3.46)	$ 1.84
Weighted Average Common Shares Outstanding
Basic	206.8	204.8	206.6	204.6
Diluted	206.8	206.2	206.6	206.0